|
|
EQSNews: BRAIN Biotech AG
/ Key words: Miscellaneous
Anniversary of BRAIN Biotech AG: 30 years for a biobased future
19.06.2023 / 12:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Anniversary of BRAIN Biotech AG: 30 years for a biobased future
Zwingenbe... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Half Year Results/Half Year Report
BRAIN Biotech AG stays on solid growth path with H1 results and accelerates OneBioProducts strategy
25.05.2023 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech AG stays on solid growth... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Mergers & Acquisitions/Strategic Company Decision
BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its OneBioProducts Strategy
24.05.2023 / 09:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: AGM/EGM
Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
08.03.2023 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.
Resolutions of the Annual General Meeting 2023 on the Financial Year... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Capital Markets Day
Capital Markets Day 2023: BRAIN Biotech AG to build an international multiniche enzyme and food ingredients champion
27.02.2023 / 16:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Capital Markets Day 2023: BRAIN Biotech AG... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Quarter Results/Quarterly / Interim Statement
BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
27.02.2023 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Agreement
BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPRderived technology platform for cancer treatment
22.02.2023 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech and TransCode Therapeutics jo... Lire le communiqué |
|
| |
|
| |
